What is the appropriate management for a 66-year-old male smoker with severe hypertriglyceridemia, severe vitamin D deficiency, elevated vitamin B12, hyponatremia, mild transaminitis, and mildly reduced estimated glomerular filtration rate?

Management of Severe Hypertriglyceridemia with Multiple Metabolic Derangements

This patient requires immediate aggressive dietary fat restriction to <10-15% of total calories (or <20-40g fat/day) to prevent acute pancreatitis, given triglycerides >1,000 mg/dL, combined with urgent correction of severe vitamin D deficiency, hyponatremia, and smoking cessation. 1

Immediate Priority: Prevent Acute Pancreatitis

With triglycerides at 1,206 mg/dL, this patient faces a 14% risk of acute pancreatitis 1. This is the most urgent mortality risk requiring immediate action:

• Implement very-low-fat diet immediately: 10-15% of total calories from fat (or <20-40g total fat/day) 1
• Eliminate all added sugars completely 1
• Eliminate alcohol entirely 1
• Refer to registered dietitian nutritionist urgently for individualized Medical Nutrition Therapy (MNT), which is essential and has been shown to reduce triglycerides regardless of medication use 1

Critical caveat: Pharmacotherapy is relatively ineffective at triglyceride levels ≥1,000 mg/dL because medications primarily reduce hepatic VLDL synthesis rather than clearing circulating chylomicrons 1. Some clinicians consider extreme dietary fat restriction (<5% of total calories) until triglycerides drop below 1,000 mg/dL 1.

Secondary Metabolic Priorities

Severe Vitamin D Deficiency (<4.0 ng/mL)

• High-dose vitamin D replacement immediately: This severe deficiency requires aggressive repletion
• Vitamin D supplementation may provide modest triglyceride reduction (6-23 mg/dL reduction in hypertriglyceridemic patients) 2
• Monitor and replete to therapeutic levels

Hyponatremia (Sodium 127 mEq/L)

• Investigate cause urgently: Rule out SIADH, volume depletion, medication effects, or adrenal insufficiency
• Correct cautiously to avoid osmotic demyelination syndrome
• This may be contributing to symptoms and requires immediate attention

Transaminitis (AST 163, ALT 77)

• Likely secondary to severe hypertriglyceridemia causing hepatic steatosis
• AST:ALT ratio >2 suggests possible alcohol contribution (patient is smoker, assess alcohol use)
• Expect improvement with triglyceride reduction
• Monitor liver function during treatment

Mildly Reduced eGFR (84 mL/min)

• Hypertriglyceridemia is independently associated with progressive kidney function decline 3
• Each 50 mg/dL increase in triglycerides increases risk of eGFR reduction (OR 1.062) and ESKD (OR 1.174) 3
• Triglyceride control may slow progression

Elevated Vitamin B12 (1,468 pg/mL)

• Generally not harmful; may reflect supplementation or dietary intake
• With reduced eGFR, ensure this isn't falsely elevated methylmalonic acid being interpreted as B12 status 4
• No intervention needed unless underlying hematologic disorder suspected

Cardiovascular Risk Management

Once Triglycerides <1,000 mg/dL:

Statin therapy is indicated for this 66-year-old male smoker with multiple ASCVD risk factors (smoking, low HDL 14 mg/dL, elevated LDL 126 mg/dL) 1, 5:

• Calculate 10-year ASCVD risk (likely high given age, smoking, lipid profile)
• Initiate moderate-to-high intensity statin
• Target LDL-C <70 mg/dL given likely high ASCVD risk 5

Consider icosapent ethyl (purified EPA) if triglycerides remain 150-499 mg/dL on statin therapy and patient has established ASCVD or diabetes with elevated cardiovascular risk 5, 6. Note: REDUCE-IT showed cardiovascular benefit (NNT=111 to prevent one CV death over 5 years), but increased atrial fibrillation and bleeding risk 7, 6.

Avoid EPA+DHA combinations as they show no meaningful cardiovascular benefit 5.

Fibrates may be considered once triglycerides are controlled to 500-999 mg/dL range to further reduce pancreatitis risk, though evidence for pancreatitis prevention is limited 7.

Critical Lifestyle Interventions

Smoking Cessation (Highest Priority for Mortality)

• Smoking cessation is mandatory - smoking is the single greatest modifiable mortality risk in this patient
• Refer to smoking cessation program immediately
• Consider pharmacotherapy (varenicline, bupropion, or nicotine replacement)
• Smokers have worse nutritional status and increased oxidative stress 8

Dietary Modifications Beyond Fat Restriction:

• Low refined carbohydrate intake (<5% calories from added sugars initially) 1
• High soluble fiber (>10g/day) 1
• Weight loss if overweight/obese 1, 9
• Increase omega-3 rich foods (though supplements ineffective for CV outcomes) 9

Physical Activity:

• Moderate-to-high intensity activity lowers triglycerides and improves body composition 7

Monitoring Plan

Week 1-2:

• Repeat triglycerides after 1-2 weeks of dietary intervention
• Monitor sodium, correct hyponatremia
• Initiate vitamin D repletion

Week 4-6:

• Reassess triglycerides; if <1,000 mg/dL, consider adding pharmacotherapy
• Recheck liver enzymes (expect improvement)
• Assess vitamin D levels

Month 3:

• Once triglycerides stabilized <500 mg/dL, shift focus to LDL-C reduction per ASCVD risk
• Monitor eGFR for stabilization

Common Pitfall: Starting fibrates or statins before aggressive dietary intervention when triglycerides are >1,000 mg/dL - these medications are relatively ineffective at this level and dietary intervention is paramount 1.